Valuation: DexCom, Inc.

Market Cap 34.52B 179B 29.92B 28.05B 25.58B 48.12B 3,295B 48.9B 330B 129B 1,649B 130B 127B 5,502B P/E 2026 *
36.7x
P/E 2027 * 30.8x
Enterprise Value 33.76B 175B 29.26B 27.43B 25.01B 47.06B 3,222B 47.82B 323B 126B 1,613B 127B 124B 5,380B EV / Sales 2026 *
6.45x
EV / Sales 2027 * 5.77x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+2.05%
1 week+11.54%
Current month+11.67%
1 month+21.72%
3 months+62.99%
6 months+39.68%
Current year+26.44%
1 week 8.65
Extreme 8.65
9.49
1 month 7.01
Extreme 7.01
9.49
Current year 5.75
Extreme 5.75
9.49
1 year 5.75
Extreme 5.75
9.49
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 31/12/2025
Director of Finance/CFO 46 18/03/2021
Chief Tech/Sci/R&D Officer - 30/04/2024
Director TitleAgeSince
Chairman 68 29/07/2018
Director/Board Member 67 19/11/2009
Director/Board Member 47 31/12/2025
Change 5-day change 1-year change 3-year change Capi.($)
+2.05%+11.54% - - 34.52B
+0.32%+3.07%-14.01%+5.66% 193B
-0.20%+5.42%-2.51%+8.54% 116B
-1.32%-4.62%+6.52%+65.45% 59.16B
+0.32%+3.92%+38.42%+65.14% 55.75B
-0.88%+2.77%-7.14%-35.54% 49.57B
+0.75%+10.19%+14.41%-18.09% 34.52B
+0.23%+3.10% - - 31.22B
-1.74%-0.70%+40.59%-12.31% 24.36B
+1.98%+12.62%-2.80%+25.91% 24.25B
Average +0.14%+4.09%+9.18%+13.10% 65.26B
Weighted average by Cap. +0.05%+3.53%+1.08%+13.53%

Financials

2026 *2027 *
Net sales 5.23B 27.17B 4.53B 4.25B 3.87B 7.29B 499B 7.41B 50.04B 19.54B 250B 19.64B 19.21B 834B 5.8B 30.13B 5.03B 4.71B 4.3B 8.09B 554B 8.21B 55.49B 21.66B 277B 21.77B 21.3B 924B
Net income 974M 5.06B 845M 792M 722M 1.36B 92.99B 1.38B 9.32B 3.64B 46.55B 3.66B 3.58B 155B 1.15B 5.97B 996M 934M 851M 1.6B 110B 1.63B 10.99B 4.29B 54.89B 4.31B 4.22B 183B
Net Debt -761M -3.95B -660M -618M -564M -1.06B -72.64B -1.08B -7.28B -2.84B -36.36B -2.86B -2.8B -121B -1.06B -5.51B -920M -863M -786M -1.48B -101B -1.5B -10.16B -3.96B -50.71B -3.99B -3.9B -169B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
13/08/26 R$9.470 +2.05% 14,264
12/08/26 R$9.280 +0.32% 364
11/08/26 R$9.250 +3.01% 1,028
10/08/26 R$8.980 +4.06% 170
07/08/26 R$8.630 +1.65% 355
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
91.48USD
Average target price
94.12USD
Spread / Average Target
+2.89%

Quarterly revenue - Rate of surprise